4.6 Article Proceedings Paper

Acute Liver Transplant Rejection Upon Immunosuppression Withdrawal in a Tolerance Induction Trial: Potential Role of IFN-γ-secreting CD8+ T Cells

Journal

TRANSPLANTATION
Volume 87, Issue 9, Pages S91-S95

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/TP.0b013e3181a2dee6

Keywords

Homeostatic proliferation; Interferon-gamma; Liver; Tolerance

Ask authors/readers for more resources

We designed a pilot trial in cadaveric liver transplantation to determine whether induction with antithymocyte globulins (ATG) and sirolimus would allow immunosuppression withdrawal. Patients received ATG 3.75 mg/kg per day from day 1 to 5 after transplantation followed by sirolimus for 4 to 6 months. We monitored interleukin (IL)-7 serum levels, interferon (IFN)-gamma, and IL-2 mRNA accumulation in mixed leukocyte reaction and intragraft IFN-gamma mRNA expression. In the first three patients, immunosuppression discontinuation was followed by reversible acute rejection occurring on days 280, 246, and 163 posttransplantation, corresponding to days 140, 40, and 39 after drug withdrawal, respectively. At the time of rejection, blood CD8(+) T-cells counts had returned to or above pretransplant levels in two of three patients, whereas CD4(+) T-cell count remained low. IL-7 serum levels rose in all three patients in the first months after transplantation and IFN-gamma mRNA accumulated in mixed leukocyte reaction between recipient T cells and donor spleen cells at the time of rejection. High levels of IFN-gamma mRNA were consistently detected in liver biopsy performed at the time of rejection. In conclusion, lymphopenia-induced IL-7 production after induction with ATG and sirolimus might lead to emergence of IFN-gamma-secreting CD8(+) T-cells responsible for acute rejection after immunosuppression withdrawal.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

IgE-mediated gastroallergic anisakiasis with eosinophilic oesophagitis: a case report

Philippe Decruyenaere, Beatrice Van de Maele, Eva Hulstaert, Hans Van Vlierberghe, Johan Decruyenaere, Hilde Lapeere

Summary: This article presents a case of gastro-allergic anisakiasis in a 58-year-old woman who developed acute IgE-mediated hypersensitivity reaction and gastrointestinal symptoms after consuming raw fish. It highlights the importance of considering Anisakis allergy as a potential cause for patients with urticarial rash, anaphylaxis, and abdominal symptoms, particularly after seafood consumption. The article also emphasizes the rare but significant complication of eosinophilic esophagitis in Anisakis infection.

ACTA CLINICA BELGICA (2022)

Article Cell Biology

Metallothioneins alter macrophage phenotype and represent novel therapeutic targets for acetaminophen-induced liver injury

Lindsey Devisscher, Sanne Van Campenhout, Sander Lefere, Sarah Raevens, Laurentijn Tilleman, Filip Van Nieuwerburgh, Hannelore P. Van Eeckhoutte, Anne Hoorens, Michael A. Lynes, Anja Geerts, Debby Laukens, Hans Van Vlierberghe

Summary: APAP intoxication leads to liver injury, with MT playing a key role in the process. Anti-MT antibody therapy can alleviate liver damage.

JOURNAL OF LEUKOCYTE BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Spatial proteogenomics reveals distinct and evolutionarily conserved hepatic macrophage niches

Martin Guilliams, Johnny Bonnardel, Birthe Haest, Bart Vanderborght, Camille Wagner, Anneleen Remmerie, Anna Bujko, Liesbet Martens, Tinne Thone, Robin Browaeys, Federico F. De Ponti, Bavo Vanneste, Christian Zwicker, Freya R. Svedberg, Tineke Vanhalewyn, Amanda Goncalves, Saskia Lippens, Bert Devriendt, Eric Cox, Giuliano Ferrero, Valerie Wittamer, Andy Willaert, Suzanne J. F. Kaptein, Johan Neyts, Kai Dallmeier, Peter Geldhof, Stijn Casaert, Bart Deplancke, Peter ten Dijke, Anne Hoorens, Aude Vanlander, Frederik Berrevoet, Yves Van Nieuwenhove, Yvan Saeys, Wouter Saelens, Hans Van Vlierberghe, Lindsey Devisscher, Charlotte L. Scott

Summary: This study presents a spatial proteogenomic atlas of the liver, combining multiple omics datasets, and reveals the cellular niches and transcriptomic identities of Kupffer cells and lipid-associated macrophages. It also demonstrates the inducibility of lipid-associated macrophages by local lipid exposure and the crucial role of ALK1-BMP9/10 axis in Kupffer cell development.
Article Gastroenterology & Hepatology

Intensive Lifestyle Management Improves Steatosis and Fibrosis in Pediatric Nonalcoholic Fatty Liver Disease

Sander Lefere, Ellen Dupont, Ann De Guchtenaere, Stephanie Van Biervliet, Saskia Vande Velde, Xavier Verhelst, Lindsey Devisscher, Hans Van Vlierberghe, Anja Geerts, Ruth De Bruyne

Summary: NAFLD and associated fibrosis are highly prevalent in children and adolescents with severe obesity. An intensive multidisciplinary lifestyle management program not only improves liver steatosis, but also fibrosis.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Article Gastroenterology & Hepatology

A multicentre outcome analysis to define global benchmarks for donation after circulatory death liver transplantation

Andrea Schlegel, Marjolein van Reeven, Kristopher Croome, Alessandro Parente, Annalisa Dolcet, Jeannette Widmer, Nicolas Meurisse, Riccardo De Carlis, Amelia Hessheimer, Ina Jochmans, Matteo Mueller, Otto B. van Leeuwen, Amit Nair, Koji Tomiyama, Ahmed Sherif, Mohamed Elsharif, Philipp Kron, Danny van der Helm, Daniel Borja-Cacho, Humberto Bohorquez, Desislava Germanova, Daniele Dondossola, Tiziana Olivieri, Stefania Camagni, Andre Gorgen, Damiano Patrono, Matteo Cescon, Sarah Croome, Rebecca Panconesi, Mauricio Flores Carvalho, Matteo Ravaioli, Juan Carlos Caicedo, George Loss, Valerio Lucidi, Gonzalo Sapisochin, Renato Romagnoli, Wayel Jassem, Michele Colledan, Luciano De Carlis, Giorgio Rossi, Fabrizio Di Benedetto, Charles M. Miller, Bart van Hoek, Magdy Attia, Peter Lodge, Roberto Hernandez-Alejandro, Olivier Detry, Cristiano Quintini, Gabriel C. Oniscu, Constantino Fondevila, Massimo Malago, Jacques Pirenne, Jan N. M. IJzermans, Robert J. Porte, Philipp Dutkowski, C. Burcin Taner, Nigel Heaton, Pierre-Alain Clavien, Wojciech G. Polak, Paolo Muiesan

Summary: The study established the best possible outcomes and reference values for liver transplantation using grafts donated after circulatory death (DCD) through benchmarking. The benchmark cases showed excellent 1-year retransplant and mortality rates, but had high rates of major complications. The use of organ perfusion technology reduced complications and improved outcomes in high-risk patients.

JOURNAL OF HEPATOLOGY (2022)

Article Medicine, General & Internal

Glycomics-based serum markers as reliable tool for assessment of viral response after treatment with direct-acting antiviral drugs in hepatitis C virus infection

Nicky Somers, Elisabeth Vandekerckhove, Anja Geerts, Helena Degroote, Sander Lefere, Lindsey Devisscher, Leander Meuris, Nico Callewaert, Hans Van Vlierberghe, Xavier Verhelst

Summary: This study assessed the inflammation-related fibrosis regression during and after treatment of HCV with DAAs using serum glycomics. The results suggest that GlycoFibroTest is a serum biomarker for viral response in HCV patients, and the rapid decrease of this glycomics-based biomarker may reflect the improvement of liver inflammation.

ACTA CLINICA BELGICA (2023)

Article Biochemistry & Molecular Biology

Gelatin-Based Hybrid Hydrogel Scaffolds: Toward Physicochemical Liver Mimicry

Nathan Carpentier, Louis Van der Meeren, Andre G. Skirtach, Lindsey Devisscher, Hans Van Vlierberghe, Peter Dubruel, Sandra Van Vlierberghe

Summary: This study developed Dexox-Gel and DexNB-GelSH hydrogels and investigated their processability and in vitro biocompatibility. The results showed that DexNB-GelSH exhibited physicochemical properties similar to natural liver tissue and had comparable performance to GelMA in biological evaluation, indicating its promising potential in the field of liver tissue engineering.

BIOMACROMOLECULES (2022)

Article Gastroenterology & Hepatology

Aminotransferases During Treatment Predict Long-Term Survival in Patients With Autoimmune Hepatitis Type 1: A Landmark Analysis

Maaike Biewenga, Xavier Verhelst, Martine Baven-Pronk, Hein Putter, Aad van den Berg, Isabelle Colle, Jeoffrey Schouten, Filip Sermon, Christophe Van Steenkiste, Hans van Vlierberghe, Adriaan van der Meer, Bart van Hoek

Summary: In patients with autoimmune hepatitis, low levels of aminotransferases during treatment are associated with better long-term survival, while immunoglobulin G is not associated with survival in the first 12 months of treatment.

CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2022)

Review Oncology

Different Models to Predict the Risk of Recurrent Hepatocellular Carcinoma in the Setting of Liver Transplantation

Helena Degroote, Anja Geerts, Xavier Verhelst, Hans Van Vlierberghe

Summary: Liver transplantation is the preferred treatment for early-stage hepatocellular carcinoma. However, there is a risk of recurrence in the transplanted liver, and predicting this risk and related prognosis for individual patients is challenging. Various scoring systems have been proposed, but there is no consensus on the optimal model or its implications in clinical practice.

CANCERS (2022)

Article Multidisciplinary Sciences

A mouse model of hepatic encephalopathy: bile duct ligation induces brain ammonia overload, glial cell activation and neuroinflammation

Wouter Claeys, Lien Van Hoecke, Anja Geerts, Hans Van Vlierberghe, Sander Lefere, Griet Van Imschoot, Elien Van Wonterghem, Bart Ghesquiere, Roosmarijn E. Vandenbroucke, Christophe Van Steenkiste

Summary: This study provides a comprehensive evaluation of a mouse model of hepatic encephalopathy and highlights the importance of neuroinflammation in the central effects of chronic liver disease.

SCIENTIFIC REPORTS (2022)

Article Gastroenterology & Hepatology

Meta-analysis: The impact of light-to-moderate alcohol consumption on progressive non-alcoholic fatty liver disease

Louise Magherman, Robbe Van Parys, Nele S. Pauwels, Xavier Verhelst, Lindsey Devisscher, Hans Van Vlierberghe, Anja Geerts, Sander Lefere

Summary: This study examined the impact of light-to-moderate alcohol consumption on progressive NAFLD and mortality. It found that moderate alcohol intake increased the risk of advanced fibrosis, liver cirrhosis, and hepatocellular carcinoma. However, light alcohol consumption appeared to protect against all-cause mortality and lower the risk of steatohepatitis. Further research is needed to provide valid recommendations for alcohol consumption in NAFLD patients.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2023)

Article Pathology

Kupffer Cells Contested as Early Drivers in the Pathogenesis of Primary Sclerosing Cholangitis

Kevin De Muynck, Bart Vanderborght, Federico F. De Ponti, Eva Gijbels, Sophie Van Welden, Martin Guilliams, Charlotte L. Scott, Alain Beschin, Mathieu Vinken, Sander Lefere, Anja Geerts, Xavier Verhelst, Hans Van Vlierberghe, Lindsey Devisscher

Summary: Primary sclerosing cholangitis (PSC) is a chronic immune-mediated liver disease characterized by bile duct strictures and fibrosis. The role of hepatic macrophages (MFs) in PSC pathogenesis is unclear. This study found that resident Kupffer cells (ResKCs) were depleted during chronic liver injury, while infiltrating monocyte-derived cells (MoKCs) were enriched during the acute phase of PSC. Depletion of KCs did not affect disease outcomes. These findings provide new insights into the heterogeneity of MFs in PSC and suggest that resident and activated KCs do not play a major role in disease progression.

AMERICAN JOURNAL OF PATHOLOGY (2023)

Article Infectious Diseases

Concurrent Ocular and Cerebral Toxoplasmosis in a Liver Transplant Patient Treated with Anti-CD40 Monoclonal Antibody

Roos van den Noortgate, Maja Kiselinova, Celine Sys, Geraldine Accou, Guy Laureys, Hans Van Vlierberghe, Frederik Berrevoet, Elke O. Kreps

Summary: We present a rare case of bilateral ocular toxoplasmosis and concurrent subacute toxoplasma encephalitis in a 70-year-old patient on anti-CD40 treatment following his liver transplant. The patient has been successfully treated with sulfamethoxazole-trimethoprim 800/160 mg, which led to complete resolution of the symptoms. Iatrogenic blockade of the CD40 pathway may increase susceptibility for CNS reactivation of T. gondii.

CASE REPORTS IN INFECTIOUS DISEASES (2023)

Article Biochemistry & Molecular Biology

Systematic comparison of experimental and human obstructive cholestasis reveals conservation of canonical pathway activation and biomarkers relevant for cholestatic liver disease

Eva Gijbels, Kevin De Muynck, Bart Vanderborght, Tim Meese, Filip Van Nieuwerburgh, Aude Vanlander, Frederik Berrevoet, Bart Hendrikx, Anne Hoorens, Hans Van Vlierberghe, Mathieu Vinken, Lindsey Devisscher

GENES & DISEASES (2023)

Article Gastroenterology & Hepatology

R3-AFP score is a new composite tool to refine prediction of hepatocellular carcinoma recurrence after liver transplantation

Charlotte Costentin, Federico Pinero, Helena Degroote, Andrea Notarpaolo, Ilka F. Boin, Karim Boudjema, Cinzia Baccaro, Luis G. Podesta, Philippe Bachellier, Giuseppe Maria Ettorre, Jaime Poniachik, Fabrice Muscari, Fabrizio Dibenedetto, Sergio Hoyos Duque, Ephrem Salame, Umberto Cillo, Sebastian Marciano, Claire Vanlemmens, Stefano Fagiuoli, Patrizia Burra, Hans Van Vlierberghe, Daniel Cherqui, Quirino Lai, Marcelo Silva, Fernando Rubinstein, Christophe Duvoux

Summary: Reassessing the risk of recurrence after liver transplantation (LT) is critical for optimizing the management of patients with hepatocellular carcinoma (HCC). In this study, a new model called R3-AFP was designed and validated based on variables associated with recurrence post-LT, providing a robust framework for designing post-LT surveillance strategies, protocols, or adjuvant therapy trials for HCC patients. The R3-AFP model outperformed the original R3 model, which was solely based on explant features.

JHEP REPORTS (2022)

No Data Available